Sectors
BOLT
Bolt Biotherapeutics, Inc.
3.98
1 x 3.80
10 x 4.25
bid
ask
-
0.01
0.25%
500 @ 04:00 PM
3.90 -0.08 (2.01%)
| Ytd | -27.24% | |
| 1y | -29.31% |
3.94
day range
4.08
3.75
52 week range
7.20
| Open | 4.04 | Prev Close | 3.99 | Low | 3.94 | High | 4.08 | Mkt Cap | 7.65M |
| Vol | 5.08K | Avg Vol | 24.45K | EPS | -16.33 | P/E | -0.24 | Forward P/E | -0.40 |
| Beta | 0.92 | Short Ratio | 0.54 | Inst. Own | 58.19% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 4.22 | 200-d Avg | 4.89 | 1yr Est | 1.75 |
| Income Statement | |||
| Total Revenue | 26.00K | ||
| Revenues (USD) | 26.00K | ||
| Gross Profit | 26.00K | ||
| Operating Expenses | 7.63M | ||
| Research and Development Expense | 4.83M | ||
| Selling, General and Administrative Expense | 2.80M | ||
| Operating Income | -7.60M | ||
| Net Income | -7.24M | ||
| Net Income Common Stock | -7.24M | ||
| Net Income Common Stock (USD) | -7.24M | ||
| Consolidated Income | -7.24M | ||
| Earnings per Basic Share | -4.31 | ||
| Earnings per Basic Share (USD) | -4.31 | ||
| Earnings per Diluted Share | -4.31 | ||
| Earning Before Interest & Taxes (EBIT) | -7.24M | ||
| Earning Before Interest & Taxes (USD) | -7.24M | ||
| Weighted Average Shares | 1.68M | ||
| Weighted Average Shares Diluted | 1.68M | ||
| Balance Sheet | |||
| Cash and Equivalents | 11.81M | ||
| Cash and Equivalents (USD) | 11.81M | ||
| Investments | 13.84M | ||
| Investments Current | 11.28M | ||
| Investments Non-Current | 2.56M | ||
| Current Assets | 25.75M | ||
| Property, Plant & Equipment Net | 19.61M | ||
| Total Assets | 48.03M | ||
| Debt Current | 2.96M | ||
| Total Debt | 22.31M | ||
| Current Liabilities | 7.34M | ||
| Debt Non-Current | 19.35M | ||
| Total Liabilities | 28.21M | ||
| Accumulated Retained Earnings (Deficit) | -468.02M | ||
| Accumulated Other Comprehensive Income | -11.00K | ||
| Shareholders Equity | 19.82M | ||
| Shareholders Equity (USD) | 19.82M | ||
| Assets Non-Current | 22.28M | ||
| Total Debt (USD) | 22.31M | ||
| Deferred Revenue | 1.98M | ||
| Liabilities Non-Current | 20.86M | ||
| Trade and Non-Trade Payables | 1.74M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 869.00K | ||
| Net Cash Flow from Financing | 6.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -94.00K | ||
| Capital Expenditure | 31.00K | ||
| Issuance (Purchase) of Equity Shares | 6.00K | ||
| Net Cash Flow from Investing | 7.92M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 7.89M | ||
| Net Cash Flow from Operations | -8.02M | ||
| Share Based Compensation | 545.00K | ||